Department of Endocrinology and Metabolism, The Second People's Hospital of Yunnan Province & The Fourth Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan, China.
Mol Genet Genomic Med. 2019 Sep;7(9):e907. doi: 10.1002/mgg3.907. Epub 2019 Aug 7.
The insulin/insulin receptor substrate (IRS)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/GLUT4 pathway plays a crucial role in insulin resistance and is closely associated with T2DM. Accumulating evidence indicates that miRNAs (such as miR-135a, let-7d, miR-107, miR-96, miR-29a, miR-23a, miR-126, miR-133a, and miR-106b) influence the GLUT4 pathway.
A total of 784 subjects with T2DM and 846 nondiabetic subjects were enrolled and 12 single nucleotide polymorphisms (SNPs) in miRNAs (rs10459194 in miR-135a-2, rs10993081 and rs7045890 in let-7d, rs2296616 in miR-107, rs2402959 and rs6965643 in miR-96, rs24168 in miR-29a, rs3745453 in miR-23a, rs4636297 in miR-126, rs8089787 and rs9948906 in miR-133a-1 and rs999885 in miR-106b) involved in the GLUT4 pathway were genotyped using the MassArray method in a Chinese population.
Our data showed that the A allele of rs2402959 in miR-96 may increase the risk of developing T2DM (p = .002, OR = 1.266; 95% CI: 1.089-1.471). The genotypes of rs3745453 in miR-23a showed the difference between T2DM and control groups (p < .001). Moreover, for rs2402959, compared with the A/A genotype, the (G/A-G/G) genotype shows a protective effect in T2DM (p = .001, OR = 0.71; 95% CI: 0.58-0.87). For rs3745453, compared with the (A/A-A/G) genotype, the G/G genotype increases the risk of T2DM (p < .001, OR = 1.95; 95% CI: 1.38-2.77). In addition, we also found that rs4636297G/G genotype was associated with lower TC in T2DM group.
Our results revealed that genetic variations in the miRNAs involved in the GLUT4 pathway were associated with T2DM susceptibility in a Chinese population, and these results emphasize the need to study the functional effects of these variations in the miRNAs involved in the GLUT4 pathway on the risk of developing T2DM.
胰岛素/胰岛素受体底物(IRS)/磷酸肌醇 3-激酶(PI3K)/蛋白激酶 B(Akt)/葡萄糖转运蛋白 4(GLUT4)通路在胰岛素抵抗中起着至关重要的作用,并且与 2 型糖尿病(T2DM)密切相关。越来越多的证据表明,miRNAs(如 miR-135a、let-7d、miR-107、miR-96、miR-29a、miR-23a、miR-126、miR-133a 和 miR-106b)会影响 GLUT4 通路。
共纳入 784 例 T2DM 患者和 846 例非糖尿病患者,并对 miRNA 中的 12 个单核苷酸多态性(rs10459194 位于 miR-135a-2、rs10993081 和 rs7045890 位于 let-7d、rs2296616 位于 miR-107、rs2402959 和 rs6965643 位于 miR-96、rs24168 位于 miR-29a、rs3745453 位于 miR-23a、rs4636297 位于 miR-126、rs8089787 和 rs9948906 位于 miR-133a-1 和 rs999885 位于 miR-106b)与 GLUT4 通路相关的单核苷酸多态性进行基因分型,采用 MassArray 方法在中国人群中进行。
我们的数据显示,miR-96 中的 rs2402959 的 A 等位基因可能会增加 T2DM 的发病风险(p =.002,OR = 1.266;95%CI:1.089-1.471)。miR-23a 中的 rs3745453 的基因型在 T2DM 和对照组之间存在差异(p <.001)。此外,与 rs2402959 的 A/A 基因型相比,(G/A-G/G)基因型在 T2DM 中表现出保护作用(p =.001,OR = 0.71;95%CI:0.58-0.87)。对于 rs3745453,与(A/A-A/G)基因型相比,G/G 基因型会增加 T2DM 的发病风险(p <.001,OR = 1.95;95%CI:1.38-2.77)。此外,我们还发现 rs4636297 的 G/G 基因型与 T2DM 组中的 TC 降低有关。
我们的研究结果表明,miRNAs 中与 GLUT4 通路相关的遗传变异与中国人群的 T2DM 易感性有关,这些结果强调了需要研究这些 miRNA 中与 GLUT4 通路相关的遗传变异对 T2DM 发病风险的功能影响。